Signals for change: A regional examination of rural clinical trial participant perspectives on values, health behaviors, and motivations for enrollment and retention in remote settings
- PMID: 40384752
- PMCID: PMC12083195
- DOI: 10.1017/cts.2025.47
Signals for change: A regional examination of rural clinical trial participant perspectives on values, health behaviors, and motivations for enrollment and retention in remote settings
Abstract
There is a known disparity in clinical trial enrollment of rural-dwelling residents in the United States, largely due to financial constraints and travel burden. A big data study of an Intermountain West rural-serving healthcare system reported strong retention rates of historically underrepresented populations with adapted approaches. This exploratory qualitative descriptive study describes the lived experience and perceptions of eleven rural residents who participated or were interested in clinical trials from this healthcare system. Thematic analysis of interviews identified co-existing dualities between culture and traditional trial models, which suggest adapted designs are necessary to achieve opportunity equity in rural regions.
Keywords: Rural health; clinical trial; community engagement; decentralized trial; ethnography.
© The Author(s) 2025.
Conflict of interest statement
The authors report no declarations of interest.
References
-
- National Academies of Sciences E, Affairs P and G, Committee on Women in Science E, Research C on I the R of W and UM in CT and, Bibbins-Domingo K, Helman A. Improving representativeness in clinical trials and research: facilitators to recruitment and retention of underrepresented groups, Improving Representation in Clinical Trials and Research: Building Research Equity for Women and Underrepresented Groups. United States: National Academies Press; 2022. - PubMed
-
- Perni S, Moy B, Nipp RD. Disparities in phase 1 cancer clinical trial enrollment. Ann Ny Acad Sci. 2021;127(23):4464–4469. - PubMed
-
- Unger JM, Fleury M. Nationally representative estimates of the participation of cancer patients in clinical research studies according to the commission on cancer. J Clin Oncol. 2021;39(28_suppl):74–74.
LinkOut - more resources
Full Text Sources